Chloasma amelioration composition and dullness amelioration composition
The present invention provides a composition that can effectively improve melasma and a composition that can effectively reduce skin dullness. The composition for improving melasma comprises a purine nucleic acid-related substance and a pharmaceutically or cosmetically acceptable carrier, and exhibits an excellent melasma improving effect due to the action of the purine nucleic acid-related substance contained. The composition for reducing skin dullness comprises a purine nucleic acid-related substance and a pharmaceutically or cosmetically acceptable carrier, and exhibits an excellent effect of reducing skin dullness due to the action of the purine nucleic acid-related substance contained.
1. A method for improving melasma, comprising applying, to a melasma lesion, an externally-applied medical or cosmetic composition comprising an adenosine monophosphate or a salt thereof, a polyglyceryl fatty acid ester, an alkanoyl lactic acid or a salt thereof, an acrylic acid-alkyl methacrylate copolymer, water, an oil, a polyhydric alcohol, and a lower alcohol having 1 to 6 carbons; wherein the proportion of the adenosine monophosphate or a salt thereof is 1 to 10 weight percent based on the total amount of the composition; wherein the adenosine monophosphate is at least one member selected from the group consisting of adenosine 2′-monophosphate, adenosine 3′-monophosphate, and adenosine 5′-monophosphate; and wherein the composition is formulated into an oil-in-water (O/W)-type emulsion.
2. The method for improving melasma according to claim 1 , wherein the polyglyceryl fatty acid ester and the alkanoyl lactic acid or a salt of the alkanoyl lactic acid are present in the composition in a weight ratio of 95:5 to 60:40.
3. The method for improving melasma according to claim 2 , wherein the polyglyceryl fatty acid ester is an ester of a C 12-36 fatty acid and a polyglycerol having a polymerization degree of 6 or more, the alkanoyl lactic acid comprises an alkanoyl group having 8 or more carbons, the acrylic acid-alkyl methacrylate copolymer comprises a C 5-40 alkyl group, and the oil is a hydrocarbon liquid oil.
4. The method for improving melasma according to claim 2 , wherein the composition comprises the polyglyceryl fatty acid ester in a proportion of 0.05 to 6 wt. %, the alkanoyl lactic acid or a salt thereof in a proportion of 0.01 to 1 wt. %, the acrylic acid-alkyl methacrylate copolymer in a proportion of 0.01 to 0.8 wt. %, the oil in a proportion of 0.3 to 20 wt. %, the polyhydric alcohol in a proportion of 0.05 to 15 wt. %, and water in a proportion of 50 to 90 wt. %, based on the total amount of the composition.
5. A method for reducing skin dullness, comprising applying, to a dullness region of the skin, an externally-applied medical or cosmetic composition comprising an adenosine monophosphate or a salt thereof, a polyglyceryl fatty acid ester, an alkanoyl lactic acid or a salt thereof, an acrylic acid-alkyl methacrylate copolymer, water, an oil, a polyhydric alcohol, and a lower alcohol having 1 to 6 carbons; wherein the proportion of the adenosine monophosphate or a salt thereof is 1 to 10 weight percent based on the total amount of the composition; wherein the adenosine monophosphate is at least one member selected from the group consisting of adenosine 2′-monophosphate, adenosine 3′-monophosphate, and adenosine 5′-monophosphate; and wherein the composition is formulated into an O/W-type emulsion.
6. The method for reducing skin dullness according to claim 5 , wherein the polyglyceryl fatty acid ester and the alkanoyl lactic acid or a salt of the alkanoyl lactic acid are present in the composition in a weight ratio of 95:5 to 60:40.
7. The method for reducing skin dullness according to claim 6 , wherein the polyglyceryl fatty acid ester is an ester of a C 12-36 fatty acid and a polyglycerol having a polymerization degree of 6 or more, the alkanoyl lactic acid comprises an alkanoyl group having 8 or more carbons, the acrylic acid-alkyl methacrylate copolymer comprises a C 5-40 alkyl group, and the oil is a hydrocarbon liquid oil.
8. The method for reducing skin dullness according to claim 6 , wherein the composition comprises the polyglyceryl fatty acid ester in a proportion of 0.05 to 6 wt. %, the alkanoyl lactic acid or a salt thereof in a proportion of 0.01 to 1 wt. %, the acrylic acid-alkyl methacrylate copolymer in a proportion of 0.01 to 0.8 wt. %, the oil in a proportion of 0.3 to 20 wt. %, the polyhydric alcohol in a proportion of 0.05 to 15 wt. %, and water in a proportion of 50 to 90 wt. %, based on the total amount of the composition.